First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid TumorsMichael L. Maitland, Emiliano Calvo, Manish Sharma et al.|Clinical Cancer Research|2021Cited by 81
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumorsShivaani Kummar, Alice P. Chen|Investigational New Drugs|2021Cited by 7